281 related articles for article (PubMed ID: 29145950)
1. A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
Natsumeda M; Florea V; Rieger AC; Tompkins BA; Banerjee MN; Golpanian S; Fritsch J; Landin AM; Kashikar ND; Karantalis V; Loescher VY; Hatzistergos KE; Bagno L; Sanina C; Mushtaq M; Rodriguez J; Rosado M; Wolf A; Collon K; Vincent L; Kanelidis AJ; Schulman IH; Mitrani R; Heldman AW; Balkan W; Hare JM
J Am Coll Cardiol; 2017 Nov; 70(20):2504-2515. PubMed ID: 29145950
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
Karantalis V; Suncion-Loescher VY; Bagno L; Golpanian S; Wolf A; Sanina C; Premer C; Kanelidis AJ; McCall F; Wang B; Balkan W; Rodriguez J; Rosado M; Morales A; Hatzistergos K; Natsumeda M; Margitich I; Schulman IH; Gomes SA; Mushtaq M; DiFede DL; Fishman JE; Pattany P; Zambrano JP; Heldman AW; Hare JM
J Am Coll Cardiol; 2015 Nov; 66(18):1990-1999. PubMed ID: 26516002
[TBL] [Abstract][Full Text] [Related]
3. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
4. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
5. Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling.
Williams AR; Suncion VY; McCall F; Guerra D; Mather J; Zambrano JP; Heldman AW; Hare JM
J Am Heart Assoc; 2013 May; 2(3):e000140. PubMed ID: 23686370
[TBL] [Abstract][Full Text] [Related]
6. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
7. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
[TBL] [Abstract][Full Text] [Related]
9. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.
Schuleri KH; Feigenbaum GS; Centola M; Weiss ES; Zimmet JM; Turney J; Kellner J; Zviman MM; Hatzistergos KE; Detrick B; Conte JV; McNiece I; Steenbergen C; Lardo AC; Hare JM
Eur Heart J; 2009 Nov; 30(22):2722-32. PubMed ID: 19586959
[TBL] [Abstract][Full Text] [Related]
10. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
Montanari S; Dayan V; Yannarelli G; Billia F; Viswanathan S; Connelly KA; Keating A
J Heart Lung Transplant; 2015 Nov; 34(11):1481-8. PubMed ID: 26234284
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
[TBL] [Abstract][Full Text] [Related]
13. Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.
Golpanian S; El-Khorazaty J; Mendizabal A; DiFede DL; Suncion VY; Karantalis V; Fishman JE; Ghersin E; Balkan W; Hare JM
J Am Coll Cardiol; 2015 Jan; 65(2):125-32. PubMed ID: 25593053
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.
Quevedo HC; Hatzistergos KE; Oskouei BN; Feigenbaum GS; Rodriguez JE; Valdes D; Pattany PM; Zambrano JP; Hu Q; McNiece I; Heldman AW; Hare JM
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):14022-7. PubMed ID: 19666564
[TBL] [Abstract][Full Text] [Related]
15. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW
J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208
[TBL] [Abstract][Full Text] [Related]
16. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
[TBL] [Abstract][Full Text] [Related]
17. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.
Oskouei BN; Lamirault G; Joseph C; Treuer AV; Landa S; Da Silva J; Hatzistergos K; Dauer M; Balkan W; McNiece I; Hare JM
Stem Cells Transl Med; 2012 Feb; 1(2):116-24. PubMed ID: 23197758
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy.
Yee K; Malliaras K; Kanazawa H; Tseliou E; Cheng K; Luthringer DJ; Ho CS; Takayama K; Minamino N; Dawkins JF; Chowdhury S; Duong DT; Seinfeld J; Middleton RC; Dharmakumar R; Li D; Marbán L; Makkar RR; Marbán E
PLoS One; 2014; 9(12):e113805. PubMed ID: 25460005
[TBL] [Abstract][Full Text] [Related]
19. Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction.
Johnston PV; Hwang CW; Bogdan V; Mills KJ; Eggan ER; Leszczynska A; Wu KC; Herzka DA; Brinker JA; Schulman SP; Banerjee M; Florea V; Natsumeda M; Tompkins B; Balkan W; Hare JM; Tomaselli GF; Weiss RG; Gerstenblith G
J Am Heart Assoc; 2019 Aug; 8(15):e012351. PubMed ID: 31340693
[TBL] [Abstract][Full Text] [Related]
20. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
